Velmetia - 2019 Drug Insight Study with Sales Forecasting to 2021 - ResearchAndMarkets.com

The "Velmetia - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.
Retrieved on: 
Monday, November 11, 2019
Information
Tags: 
Health, Pharmaceutical, Strategic management, Business intelligence, SWOT analysis, SWOT, Marketing, Articles, Economy, Microeconomics, Pharmaceutical industry, Pharmaceuticals policy
⚠generated by AI ↴
Summary
Key Points: 
  • The "Velmetia - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
  • Velmetia - Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with their location.
  • The report covers the Global Market Assessment of the Velmetia covering the historical global sales and also provides the Velmetia sales estimation during the forecasted period (2019-2021).
  • In addition to this, the report also provides the SWOT analysis for Velmetia and emerging therapies in this space.


The "Velmetia - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.

Velmetia - Drug Insight, 2019 highlights the drug marketed details and the Global API Manufacturers details across the globe along with their location.

The report covers the Global Market Assessment of the Velmetia covering the historical global sales and also provides the Velmetia sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Velmetia and emerging therapies in this space.

Scope

  • A review of the Velmetia, based on information derived from company and industry-specific sources
  • Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
  • Coverage of the Drug Master Files and API Manufacturers by country
  • Patent Expiry Timeline and Exclusivity Details
  • Route of Synthesis of the API
  • Forecasted Sales Figure from 2019-2021
  • Market competition and emerging therapies
  • SWOT Analysis

Reasons to Buy

  • Establish a comprehensive understanding of Velmetia
  • Access to drug's API manufacturers details to devise API procurement strategy for generic development
  • Plan developmental timelines around drug's patents for the major markets - US and EU
  • Understand Velmetia's current and future growth through its historical and forecasted sales
  • Identify and understand the current in-market competitors for the drug
  • Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
  • Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
  • Identify opportunities in the same area as Velmetia with the SWOT analysis

Key Topics Covered

1. Report Introduction

2. Velmetia - Overview

  • Product Description
  • Route of Synthesis
  • Mechanism of Action
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Adverse Reactions
  • Regulatory Milestones by Region
  • Deals and Partnerships

3. Product Details

4. Velmetia Sales Assessment

  • Historical Sales
  • Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

  • Active Pharmaceutical Ingredient (API) Manufacturers by Country
  • Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

  • Product Description
  • Research and Development
  • Product Development Activities

9. SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/ykwbba

Copyright: 
Copyright Business Wire 2019